A Path to Precision Metabolic Treatment in Breast Cancer: Riluzole, Glutamate Signaling, and Invasive Lobular Carcinoma. | J Endocr Soc;8(2): bvad171, 2024 Jan 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Biblioteca Virtual en Salud

BVS - Literatura Cientifica y Técnica

Localizar descriptor de asunto Búsqueda Avanzada

A Path to Precision Metabolic Treatment in Breast Cancer: Riluzole, Glutamate Signaling, and Invasive Lobular Carcinoma.

Sikora, Matthew J; Ostrander, Julie H.

Sikora MJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Ostrander JH; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

J Endocr Soc ; 8(2): bvad171, 2024 Jan 05.

Article en En | MEDLINE | ID: mdl-38193025

Palabras clave

PET/CT; anti-estrogen; breast cancer; glutamate; invasive lobular carcinoma; metabolism

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article